Search by Drug Name or NDC
NDC 55150-0196-99 Ropivacaine Hydrochloride 2 mg/mL Details
Ropivacaine Hydrochloride 2 mg/mL
Ropivacaine Hydrochloride is a EPIDURAL; INFILTRATION; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is ROPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 55150-0196 |
|---|---|
| Product ID | 55150-196_5c702449-8911-42f1-8057-139cef400fb8 |
| Associated GPIs | 69100070102008 |
| GCN Sequence Number | 028219 |
| GCN Sequence Number Description | ropivacaine HCl/PF INFUS. BTL 2 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 46083 |
| HICL Sequence Number | 036674 |
| HICL Sequence Number Description | ROPIVACAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | Ropivacaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ropivacaine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INFILTRATION; PERINEURAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205612 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0196-99 (55150019699)
| NDC Package Code | 55150-196-99 |
|---|---|
| Billing NDC | 55150019699 |
| Package | 1 BOTTLE, GLASS in 1 CARTON (55150-196-99) / 100 mL in 1 BOTTLE, GLASS |
| Marketing Start Date | 2016-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |